Bahl & Gaynor’s Synopsys SNPS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$306K Buy
771
+19
+3% +$8.59K ﹤0.01% 302
2025
Q4
$353K Sell
752
-1,154
-61% -$513K ﹤0.01% 300
2025
Q3
$940K Buy
+1,906
New +$1.08M ﹤0.01% 236

Other funds holding SNPS

Bahl & Gaynor's SNPS Position: Q1 2026 in Review

Bahl & Gaynor increased its Synopsys (SNPS) stake by 2.5% in Q1 2026, buying an estimated $8.59K and bringing the position to 771 shares worth $306K. The position accounts for ﹤0.01% of the portfolio, ranked #302.

Bahl & Gaynor first reported a position in SNPS in Q3 2025 and has held it in 3 quarters since. The position peaked at $940K in Q3 2025. 1,395 funds tracked by Wall St. Rank hold SNPS as of Q1 2026.

  • Bahl & Gaynor held 771 shares of Synopsys worth $306K as of Q1 2026.
  • Bahl & Gaynor bought 19 Synopsys shares in Q1 2026, an estimated $8.59K.
  • Synopsys made up ﹤0.01% of Bahl & Gaynor's portfolio in Q1 2026, its #302 holding.
  • Bahl & Gaynor first reported a position in Synopsys in Q3 2025 and has held it in 3 quarters since.
  • Bahl & Gaynor's Synopsys position peaked at $940K in Q3 2025.
  • 1,395 funds tracked by Wall St. Rank held Synopsys as of Q1 2026.

Based on Bahl & Gaynor's 13F filing for Q1 2026, filed 7 May 2026.